Skip to main content

. 1977 Apr;4(2):241–242. doi: 10.1111/j.1365-2125.1977.tb00703.x

Plasma nitroglycerin levels after sublingual, oral and topical administration.

H P Blumenthal, H L Fung, E F McNiff, S K Yap

PMCID: PMC1429026 PMID: 405030

241

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Needleman P., Lang S., Johnson E. M., Jr Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther. 1972 Jun;181(3):489–497. [PubMed] [Google Scholar]
Parker J. O., Augustine R. J., Burton J. R., West R. O., Armstrong P. W. Effect of nitroglycerin ointment on the clinical and hemodynamic response to exercise. Am J Cardiol. 1976 Aug;38(2):162–166. doi: 10.1016/0002-9149(76)90143-0. [DOI] [PubMed] [Google Scholar]
Rosseel M. T., Bogaert M. G. GLC determination of nitroglycerin and isosorbide dinitrate in human plasma. J Pharm Sci. 1973 May;62(5):754–758. doi: 10.1002/jps.2600620510. [DOI] [PubMed] [Google Scholar]
Winsor T., Berger H. J. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design. Am Heart J. 1975 Nov;90(5):611–626. doi: 10.1016/0002-8703(75)90226-4. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES